Business · 09/08/1999
FDA Clears Bendectin for Sale, Allows for Generic Versions
The US Food and Drug Administration (FDA) has ruled that Bendectin, a pregnancy prevention medication, was not withdrawn due to safety or effectiveness concerns, paving the way for generic versions of the drug.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →